DNA methylation is thought to be robust to environmental perturbations on a short time scale. Here, we challenge that view by demonstrating that the infection of human dendritic cells (DCs) with a pathogenic bacteria is associated with rapid changes in methylation at thousands of loci. Infection-induced changes in methylation occur primarily at distal enhancer elements, including those associated with the activation of key immunetranscription factors and genes involved in the crosstalk between DCs and adaptive immunity. Active demethylation is associated with extensive epigenetic remodeling and is strongly predictive of changes in the expression levels of nearby genes. Collectively, our observations show that rapid changes in methylation play a previously unappreciated role in regulating the transcriptional response of DCs to infection.
The first immune mechanisms recruited to defend against invading pathogens are those associated with innate immune cells, such as dendritic cells (DCs) or macrophages. Once they sense an intruder, these cells induce sophisticated transcriptional programs involving the regulation of thousands of genes, which are coordinated with the help of signal-dependent transcription factors, including NF-κB/Rel, AP-1, and interferon regulatory factors (IRFs) 1, 2 . The regulation of this program is achieved through a series of epigenetic changes, which modulate the access of transcription factors to specific DNA regulatory elements 3 .
The most well-studied epigenetic responses to immune stimuli involve the post-translational modification of histone tails at promoter and enhancer regions 3, 4 . Histone acetylation has been shown to be essential for the activation of many pro-inflammatory genes 5, 6 , whereas increased activity of histone deacetylases is often associated with gene repression in the context of inflammation 7 . Moreover, recent studies suggest that the response of innate cells to different immune challenges can result in the appearance of histone marks associated with de novo enhancer elements (or latent enhancers) 8, 9 , which have been postulated to contribute to a faster and stronger transcriptional response to a secondary stimulus 8 .
In contrast, we still know remarkably little about the role of other epigenetic changes in controlling responses to infection. DNA methylation has been particularly understudied, as a consequence of the belief that methylation marks are highly stable, and unlikely to respond to environmental perturbations on a short time scale. Recent work, however, suggests that DNA methylation patterns can rapidly change in response to certain environmental cues [10] [11] [12] [13] , raising the possibility that rapid changes in DNA methylation might play a role in innate immune responses. Yet, to date, no studies have comprehensively investigated the contribution of rapid, active changes in methylation (in contrast to passive changes during cell replication) to the regulatory programs induced by innate immune cells in response to an infectious agent. More broadly, the few studies that demonstrate active regulation of DNA methylation in mammalian cells have been focused on a limited number of CpG sites and, surprisingly, the changes observed have been poorly predictive of changes in gene expression levels 10, 12, 13 . Here, we show that active changes in DNA methylation are pervasive in response to infection and, in contrast to previous reports; we found that such changes have a strong predictive impact on gene expression levels. Specifically, we report the first comprehensive epigenome and transcriptome of monocyte-derived DCs -professional antigen presenting cells that play a central role in bridging innate and adaptive immunity -before and after in vitro infection with live pathogenic bacteria.
Our results thus provide unique insight into the role of active changes in methylation and their association with other epigenetic changes in the control of innate immune responses to infection.
RESULTS

MTB infection induces active changes in DNA methylation in human DCs
We infected monocyte-derived DCs from six healthy donors with a live virulent strain of Mycobacterium tuberculosis (MTB), the causative agent of tuberculosis (TB) in humans.
Monocyte-derived DCs are ideally suited to study active changes in methylation given that they are post-mitotic and that they do not proliferate in response to infection 14, 15 . At 18 hours after infection, we obtained paired data on single-base-pair resolution DNA methylation levels (using whole genome shotgun bisulfite sequencing: i.e., MethylC-Seq) and genome-wide gene expression data (using mRNA sequencing: i.e., mRNA-Seq) in non-infected and MTB-infected DCs. For MethylC-Seq data, we generated 8.6 billion single-end reads (mean of 648 ± 110 SD million reads per sample; Supplementary Table 1 ) resulting in an average coverage per CpG site of ~9X for each sample. We detected an average of 24 million CpG sites in each sample, corresponding to over 80% of CpG sites in the human genome. Genome-wide methylation data between biological replicates was strongly correlated attesting for the high quality of the data ( Supplementary Fig. 1 ; mean r across all samples = 0.86).
As expected for mammalian cells, CpG sites were ubiquitously methylated throughout the genome except near transcription start sites (TSSs) and in CpG islands ( Supplementary Fig.   2a,b) . We found a significant negative correlation between gene expression levels and methylation levels around TSSs (r = -0.39; P < 1 × 10 -16 ; Supplementary Fig. 2c,d) ,
highlighting the well-established role of proximal methylation in the stable silencing of gene expression. Principal component analysis of our data along with MethylC-Seq data from 21 other purified cell types and tissues revealed that the DC methylome is closely related to that of other blood-derived cells, particularly cells that share a common myeloid progenitor with DCs, such as neutrophils ( Supplementary Fig. 2e ).
We next assessed the occurrence and the extent to which the response of DCs to a bacterial infection is accompanied by active changes in DNA methylation, using the BSmooth algorithm 16 . We defined MTB-induced differentially methylated regions (MTB-DMRs) as regions of 3 or more consecutive CpG sites exhibiting a significant difference in methylation between the two groups (P < 0.01) and an absolute mean methylation difference above 0.1 17 .
Using these criteria, we identified 3,271 MTB-DMRs, within which 1,557 corresponded to hypermethylated regions (i.e., regions in which methylation levels increased upon infection; mean length = 134 bp) and 1,714 to hypomethylated regions (i.e., regions in which methylation levels decreased upon infection; mean length = 184 bp) ( Fig. 1a and Supplementary Table 2 ).
Interestingly, we found that less than 7% of MTB-DMRs overlapped with a putative promoter ( Fig. 1b) and that the vast majority of these sites were located distal to TSSs (median distance of ~35 kb from the nearest TSS; Fig. 1c ). MTB-DMRs occur in genomic regions that show increased levels of evolutionary conservation (Fig. 1d) , a finding supporting that they are functionally important. Moreover, gene ontology analysis revealed that MTB-DMRs are significantly enriched (false discovery rate (FDR) < 0.05) near genes known to play a key role in the regulation of immune processes, including the regulation of transcription, signal transduction, and, importantly, cell apoptosis -a critical mechanism assisting DC cross-presentation to adaptive immune cells ( Fig. 1e) . Notably, hypomethylated regions show a stronger enrichment for genes involved in DC-T cell crosstalk, suggesting that active demethylation plays a particularly important role in dictating the nature and magnitude of the T cell response to infectious agents ( Fig. 1e ).
Active Changes in Methylation Occur in Regions Enriched for 5-hydroxymethylcytosine
The TET family proteins catalyze the conversion of methylated cytosine (5mC) to 5-hydroxymethylcytosine (5hmC), and are thus key players in the process of active demethylation. To evaluate if 5hmC were dynamically changing in response to MTB infection (as expected if 5mC sites must pass through the 5hmC state before demethylation), we generated single-base pair resolution maps of 5hmC across the genome using Tet-assisted bisulfite sequencing (TAB-Seq) 18 in one additional donor. As previously described for other cell populations 19, 20 , we found markedly higher levels of 5hmC in gene bodies of highly expressed genes, consistent with a role for 5hmC in maintaining and/or promoting gene expression ( Fig. 2a) 21, 22 .
Next, we evaluated if 5hmC marks were enriched within MTB-DMRs. We found that regions in which methylation actively changed in response to infection were already associated with significantly higher levels of 5hmC prior to infection (2.6-and 3.6-fold enrichments for hyperand hypomethylated regions; Wilcoxon test; P < 1 × 10 -16 , respectively). Upon infection, hypomethylated regions show increased levels of 5hmC (Wilcoxon test; P = 1.57 × 10 -11 ; Fig.   2b ,c), which suggests that 5hmC plays an important role in the cascade of events leading to active demethylation. The increase in 5hmC appears to be specific to hypomethylated regions: no enrichment was observed in hypermethylated regions or genome-wide, a result supported by quantitative immunocytochemistry data ( Fig. 2d,e ). The striking enrichment of 5hmC within MTB-DMRs prior to infection strongly suggests that, in addition to its role as a transitory demethylation intermediate, 5hmC might also serve additional regulatory functions including the coordination of the gene expression program induced in response to a microbial stimulus.
MTB-DMRs overlap with enhancer elements that gain activation marks upon infection
Given that MTB-DMRs are primarily found distal to TSSs, we predicted that MTB-DMRs would overlap with enhancer regions. To test this hypothesis and evaluate how the chromatin states associated with MTB-DMRs might dynamically change in response to infection, we collected ChIP-Seq data for six histone marks (H3K4me1, H3K4me3, H3K27ac, H3K27me3, H3K36me3 and H3K9me3) in non-infected and infected DCs ( Supplementary Table 1 ) from two additional donors. Using these data, we generated genome-wide, gene regulatory annotation maps for noninfected and MTB-infected DCs using the ChromHMM chromatin segmentation program ( Fig.   3a and Supplementary Fig. 3 ) 23 . We found that 37% of MTB-DMRs overlapped with a ChromHMM-annotated enhancer region (defined by the presence of H3K4me1) already present in non-infected DCs, a 6.7-fold enrichment compared to genome-wide expectations (χ2-test; P < 1 × 10 -16 ; Fig. 3b ,c, and Supplementary Table 2 ). Similar enrichments (6.7-fold; P < 1 × 10 -16 )
were observed when defining chromatin states in MTB-infected DCs. Given the high-resolution of our histone maps, we could further distinguish between active and inactive/poised enhancer elements based on the presence or absence of the H3K27ac mark, respectively, in addition to H3K4me1 [24] [25] [26] . Overall, we found that MTB infection leads to a significant increase of active enhancer elements (and decrease of inactive/poised enhancers) colocalizing with MTB-DMRs ( Fig. 3b,c) .
Previous studies have shown that enhancer activation and inactivation are associated with local CpG hypomethylation and hypermethylation, respectively 20 . We therefore extended our analysis by examining chromatin transition states at hyper-and hypomethylated regions. In hypermethylated regions, we found no evidence for an enrichment in the proportion of regions whose chromatin state annotation changed in response to infection, compared to the genomewide background ( Fig. 3e and Supplementary Fig. 4 ). Conversely, 42% of hypomethylated regions occurred in regions that exhibited infection-dependent changes in chromatin state, a significantly higher proportion than expected compared to the rest of the genome (P resampling < 0.001; Fig. 3e ). The chromatin state transitions observed within hypomethylated regions were primarily explained by the acquisition of histone activating marks (e.g., H3K27ac) in MTBinfected cells. For example, among hypomethylated regions that overlapped with predefined enhancers (i.e., enhancers observable in non-infected cells), 85% of those that exhibit a change in chromatin state gained an activation mark (H3K27ac or H3K27ac+H3K4me3; Fig. 3f ,g and Supplementary Fig. 5 ). This proportion was markedly larger than that observed in hypermethylated regions (34%) or genome-wide (44%) (χ2-test; P < 8.3 × 10 -5 ; Fig. 3f ).
Notably, we also found a large number of hypomethylated regions (n = 218; 12.7% of all hypomethylated DMRs) that overlapped with heterochromatin/repressed regions before infection but gained de novo enhancer marks upon MTB infection (H3K4me1 (+ H3K27ac + H3K4me3)).
The number of de novo enhancers we observed among hypomethylated DMRs was significantly higher than expected by chance (P resampling < 0.001; Fig. 3d ,e,g and Supplementary Fig. 5 ). The identification of enhancers only present in infected DCs resembles recent findings in mouse macrophages showing that in response to different immune stimuli they can gain de novo putative enhancer regions that were absent in naive cells 8,9 . Interestingly, MTB-induced activation or de novo gain of enhancer elements at hypomethylated regions is associated with the induction of putative enhancer RNAs (eRNAs) 27 in these intergenic regions (as measured by whole-transcriptome RNA-seq) as well as with increased levels of histone marks associated with transcriptional activity (Supplementary Fig. 6 ).
Moreover, changes in eRNA levels in response to MTB infection show a striking positive correlation with changes in gene expression levels of nearby genes (r = 0.49, P = 7.6 × 10 -13 ; Supplementary Fig. 6) , in support to a mechanistic link between demethylation, eRNA production and the regulation of proximal protein-coding genes 28 .
MTB-DMRs are bound by signal-dependent transcription factors
We next asked if MTB-infection was associated with changes in the levels of chromatin accessibility in MTB-DMRs. We mapped regions of open chromatin in non-infected and infected DCs based on genome-wide sequencing of regions showing high transposase (Tn5) sensitivity (using ATAC-Seq in one additional donor) 29 . Overall, we observed that MTB-DMRs colocalize
with regions of open chromatin, which further reinforces the regulatory potential of these regions ( Fig. 4a) . Interestingly, we found that the response to MTB-infection was accompanied by a striking increase in Tn5 sensitivity levels in hypomethylated regions, which indicates that the chromatin in these regions became more accessible after infection ( Fig. 4a) . This observation is commensurate with our data showing the acquisition of active histone marks in these regions, and further supports the idea that hypomethylated regions frequently reflect the presence of regulatory elements that become more active in response to infection.
An attractive feature of ATAC-Seq data is the ability to identify motif instances occupied by transcription factors (TF) within regions of open chromatin 29, 30 . We did so by using a modified version of the Centipede algorithm 31 specifically devised to test for aggregate differential binding of TFs between two experimental conditions. This method, which we coined CentiDual, compares the intensity of the Tn5 sensitivity-based footprint across all matches to a given motif in the genome, between non-infected and infected samples (see Online Methods for details on the statistical model). We found compelling evidence for measurable, genome-wide transcription factor activity (i.e., binding to the genome; Bonferroni-corrected P < 0.05) in either non-infected or infected DCs for 264 TF binding motifs, representing over 200 unique transcription factors (some TFs can bind different motifs; Supplementary Table 3 ). Of these TF binding motifs, we found 56 that were differentially bound between non-infected and infected DCs (Bonferroni-corrected P < 0.05; 26 show increased binding and 29 show decreased binding; Fig. 4b ). Among TF binding motifs showing increased genome-wide binding after infection, we found several NF-κB and IRF family members ( Fig. 4b and Supplementary Table 3 ), both of which play a primary role in the regulation of inflammatory signals in response to infection 2 . Interestingly, several CTCF motifs showed significantly decreased binding in infected DCs (Bonferronicorrected P < 1.85 × 10 -14 , Supplementary Table 3 ). CTCF is a well-established transcriptional insulator 32 , raising the possibility that the release of CTCF in response to infection might represent an important mechanism for the regulation of efficient immune responses.
We next used CentiDual to test for differential binding within MTB-DMRs. We found no significant evidence of differential binding for any of the 264 TF binding motifs tested within hypermethylated regions. In contrast, within hypomethylated regions we found increased binding (FDR < 0.1) at 8 TF binding motifs after infection ( Supplementary Table 3 ). Strikingly, all of these motifs were associated with immune-induced TFs from the NF-κB (e.g., REL; FDR = 1.57 × 10 -6 ), AP-1 (FDR = 4.9 × 10 -3 ), or IRF (FDR = 3.97 × 10 -3 ) families ( Fig. 4c) , which demonstrates that hypomethyated regions correspond to places where immune-activated TFs are being recruited. In accordance, we found that, in infected DCs, NF-κB, AP-1, and IRFs were all significantly enriched within MTB-DMRs (up to 16-fold), particularly within hypomethylated regions ( Fig. 4d) . Indeed, in MTB infected DCs, over 50% of the hypomethylated regions were bound by at least one of these signal-dependent TFs, which corresponds to an 3.8-fold increase relative to expectation (based on sampling random regions of the genome matched for length and GC content; Supplementary Fig. 7 ; χ2-test; P = 3.94 × 10 -63 ).
MTB-DMRs are associated with genes differently expressed in response to MTB infection
Finally, we asked if genes associated with MTB-DMRs were more likely to change expression levels in response to infection. We classified 1,665 and 1,740 genes as significantly up-or downregulated post-infection, respectively (FDR < 1 × 10 -4 & |log2 fold-change| > 1; Supplementary   Table 4 ). We next tested whether genes located nearby MTB-DMRs were more likely to be differentially expressed upon MTB infection relative to all genes in the genome. To do so, we first associated each MTB-DMR with a unique gene using the following criteria: if an MTB-DMR was located within a gene body, the MTB-DMR was assigned to that gene; otherwise, we assigned each MTB-DMR to the gene with the TSS closest to the midpoint of the MTB. Then, we tested for an enrichment of differentially expressed (DE) genes among five classes of genes:
(i) "DMR-genes" corresponding to all genes associated with MTB-DMRs (n = 2,160); (ii) "hyper-DMR-genes" corresponding to the set of genes associated with hypermethylated regions (n = 1,137); (iii) "hypo-DMR-genes" corresponding to the set of genes associated with hypomethylated regions (n = 1,201); (iv) "predefined-DMR-genes" corresponding to the set of genes in hypomethylated regions that overlapped with predefined enhancer elements (n = 470, a subset of class iii), and (v) "de novo-DMR-genes" corresponding to the set of genes in hypomethylated regions that overlapped with de novo enhancer elements (n = 161, also subset of class iii).
We found that DMR-genes (class i) were significantly enriched among DE genes (1.4-fold, χ2test; P = 1.27 × 10 -11; Fig. 5a ,b) as compared to all genes in the genome. This enrichment was noticeably stronger for predefined-DMR-genes (class iv; 1.9-fold, P = 3.1 × 10 -11 ) and even more so for de novo-DMR-genes (class v; 2.3-fold, P = 1.1 × 10 -9 ). Indeed, among de novo-DMRgenes, 49% were DE, even at very stringent cutoffs we used to define DE genes ( Fig. 5a,b ).
Interestingly, among DE genes associated with hypomethylated regions, 73% were up-regulated after MTB infection -substantially more than the 51% of up-regulated genes observed genomewide (χ2-test; P = 1.41 × 10 -73 , Fig. 5c ). This observation was even more pronounced when focusing specifically on predefined-DMR-genes (class iv) and de novo-DMR-genes (class v), for which 78% (P = 5.46 × 10 -34 ) and 92% (P = 1.39 × 10 -19) , respectively, were associated with increased expression levels in response to infection ( Fig. 5c) . Interestingly, the biological functions linked to predefined enhancer-associated genes differed from those linked to de novo enhancer-associated genes, even though both types of enhancers occurred in hypomethylated DMRs. Specifically, DE genes associated with predefined enhancer elements that loose methylation in response to infection were mainly enriched for signal transduction processes (FDR < 0.01). This set of genes included virtually all the key "master-regulators" of innate immune responses, such as NFKB1, NFKB1A, IRF2, and IRF4 (Fig. 5d ). In contrast, DE genes associated with de novo enhancers appear to be more directly involved in processes related to the ability of DCs to activate B and T cells (FDR < 0.01; e.g., CD83) and the regulation of cell death (FDR < 0.01; e.g., BCL2) ( Supplementary Table 5 ).
DISCUSSION
The possibility that active changes in methylation, particularly demethylation, can occur in mammals has been a matter of debate for decades 33, 34 . Here, we provide with compelling evidence that the response of human DCs to MTB infection is accompanied by widespread, rapid changes in DNA methylation that involve both active demethylation and de novo methylation.
Several mechanisms could account for the observed active changes in methylation. De novo methylation is likely explained by the action of DNA methyltransferases (DNMT), namely DNMT3 35 . For demethylation many possible mechanisms can potentially be invoked 36 ; however, the observation that hypomethylated regions show increased levels of 5hmc in response to MTB infection strongly suggests that the family of TET proteins (TET1-3) are involved in this process.
This possibility is further supported by recent studies showing that TET2 was required for active DNA demethylation in human monocytes 13 and during brain development 20 .
By integrating our methylation maps with ChIP-Seq data on six histone marks we show that active methylation changes occur almost exclusively at distal regulatory elements, namely enhancers. This observation, which is robust to the cutoffs used to call MTB-DMRs ( Supplementary Fig. 8 ), parallels what has been previously described in differentiating cells and during developmental processes [37] [38] [39] despite the fact that the mechanisms controlling active and passive changes in methylation are markedly different 36 . In stark contrast to previous studies that also reported active changes in methylation, for example, in response to neuronal activation 10 or during the process of differentiation of human monocytes into macrophages or dendritic cells 13 , we found a strong association between DMRs and changes in gene expression of nearby genes.
The apparent discrepancy between our results and those previously reported is probably explained by the fact that past studies have only investigated active methylation changes in promoter regions -that we show to be infrequent -or only on a small subset of all CpG sites in the (mouse) genome (~1%). Moreover, we decided to focus on differently methylated regions (3 or more consecutive differently methylated CpGs) instead of methylation changes at individual CpG sites 10, 13 , which is likely to enrich for DMRs that are more directly linked to changes in gene expression. In support to that hypothesis, we found that the enrichment for DE genes become stronger as we focus on DMRs with a larger number of differently methylated CpG sites ( Supplementary Fig. 8 ). More broadly, our results highlight the key importance of using singlebase resolution map of the DNA methylome in order to fully capture the relationship between changes in methylation and changes in gene expression.
Interestingly, we found that the loss of methylation at enhancer elements is often associated with the gain of histone activation marks and the recruitment of immune-activated TFs (e.g., NF-κB and IRFs) to these regions in response to infection. The recruitment of NF-κB and other master regulators to hypomethylated regions is likely associated with the opening of the chromatin in these regions, although it remains unclear whether the chromatin opens to allow the binding of these TFs (i.e., prior to binding) or if the observed increase in chromatin accessibility is a consequence of the binding itself. It also remains to be further explored whether the observed changes in methylation are required to allow TF binding or if it is the binding of TFs to these regions that leads to the loss of methylation, as previously proposed in other cellular contexts 39, 40 . Our analyses do indicate, however, that even if TF binding is the instigating factor to the observed changes in methylation, binding alone is not sufficient given that the vast majority (>99%) of binding events induced by infection occur at regions that do not change methylation (Supplementary Fig. 9 ).
There is mounting evidence that after a first encounter with a pathogen or other immune stimulus innate immune cells keep such attacks "in memory", leading to faster and stronger gene transcriptional responses upon restimulation and increased resistance to secondary infection. This process, termed trained immunity 4, 41, 42 , has been attributed to epigenetic reprograming at the level of histone H3 methylation based on the observation that distal regulatory elements that gain de novo H3K4me1 (i.e., de novo enhancer marks) in response to immune activation generally do not lose this mark after the stimulation has ceased 8 . Although epigenetic programming through histone modifications might be an important factor in trained immunity, our results raise the possibility that changes in DNA methylation might also contribute to shortterm memory in innate immune cells. Indeed, changes in DNA methylation might be ideally suited as a mechanism of epigenetic memory since these changes are expected to be thermodynamically more stable and longer lasting than changes in histone marks. Based on our current data, it is hard to assess the degree to which MTB-induced changes in DNA methylation remained stable over time. However, many of the genes associated with DMRs are wellrecognized as early response genes (e.g., NFKB1, IRF2, IRF4, IRF8 are upregulated minutes after an immune challenge 43, 44 or genes that only respond to MTB infection at early time points (e.g., DUSP2, MAP2K3, MAP3K4) 45 . This observation strongly suggests that some of the changes in methylation are likely to have occurred in the first hours after infection and have remained stable over time. Moreover, we show that the gain of de novo enhancers -assumed to account for trained immunity -often occurs concomitantly with the loss of DNA methylation in the same regions. Our results thus raise the possibility that trained immunity might not only be due to post-transcriptional changes in histone marks but also, and possibly primarily, due to changes in DNA methylation.
Collectively, our results suggest that active and rapid changes in methylation might play a previously unappreciated and critical role in the transcriptional regulation of an efficient immune response to infection. They also highlight the key importance of multiple and coordinated epigenetic changes in enhancer regions at dictating the regulatory programs induced in response to a live pathogenic bacteria.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper. Normalized read counts for the indicated features are shown for non-infected (blue tracks) and infected conditions (red tracks).
ONLINE METHODS
Sample collection. Blood samples were obtained from the Indiana Blood Center. A signed written consent was obtained from all of the participants and the project was approved by the ethics committee at the CHU Sainte-Justine (protocol #4023). All individuals recruited in this study were healthy Caucasian males between the ages of 21 and 55 y old. We decided to only focus on males to limit the variation in methylation estimates due to sex-specific differences.
Only individuals self-reported as currently healthy, not under medication, and with no history of chronic diseases were included in the study. In addition, each donor's blood was tested for standard blood-borne pathogens, and only samples negative for all of the pathogens tested were included.
Mycobacterium tuberculosis preparation. We infected dendritic cells (DCs) with a
Mycobacterium tuberculosis (MTB) strain expressing green-fluorescent protein (H37Rv) 47, 48 .
Importantly, previous studies have shown that the presence of GFP in this strain does not alter the growth rate or the virulence of the bacilli under axenic conditions, relative to wild-type MTB.
M. tuberculosis H37Rv was grown from a frozen stock to midlog phase in 7H9 medium (BD) supplemented with albumin-dextrose-catalase (ADC; Difco) 48, 49 . For biosecurity reasons the ChIP-Seq and ATAC-Seq experiments were performed using heatkilled bacteria instead of live MTB. In order to evaluate the extent to which using heat-killed bacteria could result in a different transcriptional response to that induced by live MTB, we used the Illumina HumanHT-12 v4 Expression BeadChip array to compare the genome-wide transcriptional responses observed in DCs in response to live MTB to those observed when DCs from the same donors were exposed to different amounts of heat-killed MTB bacteria. Low-level microarray processing including normalization of the data and variance stabilizing transformation were performed as previously described 47 . We found that using the equivalent of 5 heat-killed bacteria to 1 DC leads to virtually the same transcriptional response at 18 hours to that observed with live MTB (r = 0.91; Supplementary Fig. 10 ).
Isolation and infection of DCs. Peripheral blood mononuclear cells (PBMCs
DNA and RNA Extractions. DNA from infected and non-infected DCs was extracted using the
PureGene DNA extraction kit (Gentra Systems). Total RNA was extracted from the same samples using the miRNeasy kit (Qiagen). RNA quantity was evaluated spectrophotometrically, and the quality was assessed with the Agilent 2100 Bioanalyzer (Agilent Technologies). Only samples with no evidence for RNA degradation (RNA integrity number > 8) were kept for further experiments. Tet-assisted bisulfite sequencing (TAB-Seq). TAB-Seq libraries were performed as previously described 18 and a detailed protocol will be provided upon request. Briefly, genomic DNA was spiked with 0.25% of M. SsI methylated lambda DNA and 0.25% of 5hmC spike-in control II (where all cytosines were 5hmC) and then sonicated to 200-500bp with a Covaris ultrasonicator.
MethylC-Seq library preparation and sequencing. DNA from infected and non-infected DCs
The M. SsI methylated lambda DNA and the 5hmC spike-in control were used to evaluate the conversion rate of 5mC and protection rate of 5hmC, respectively (see TAB-Seq data processing section). Next, we use b-glucosyltransferase (bGT) to introduce a glucose onto 5hmC, generating b-glucosyl-5-hydroxymethylcytosine (5gmC) to protect 5hmC from further TET oxidation. After blocking of 5hmC, all 5mC is converted to 5caC by oxidation with an excess of recombinant Tet1 protein. Bisulfite treatment of the resulting DNA then converts all C and 5caC (derived from 5mC) to uracil or 5caU, respectively, whereas the original 5hmC bases remain protected as 5gmC. Thus, following sequencing, only the 5hmC that were protected from bisulfite conversion will be read as cytosine bases. After the treatment, we performed bisulfite conversion and library preparation following a protocol identical to that for the MethylC-Seq libraries (described above). Samples were sequenced on an Illumina HiSeq 2000 using 100-bp paired-end reads. 5hmC staining. The protocol was adapted from Santos et al. 50 . Briefly DCs were cultured on poly-L-lysine-coated coverslips. Cells were fixed for 30 min in 4% paraformaldehyde in PBS and permeabilized with 0.2% Triton X-100 in PBS for 30 min at room temperature (RT). Cells were then washed with 0.05% Tween 20 in PBS and were treated with 1M HCl plus 0.1% Triton X-100. After 30 min at 37°C, cells were incubated with 100mM tris/HCl (pH 8.5) for 30 min and blocked for 2h in PBS with 1% BSA, 0.05% Tween-20 and 2% goat serum. Cells were incubated with 5-Hydroxymethylcytosine antibody (ActiveMotif), followed by Alexa 488 goat anti-rabbit antibody (Life Technologies) 1h at RT. The slides were mounted with Fluoromount G (SouthernBiotech), and cells counterstained with DAPI to localize the nucleus. A laser-scanning microscope (Zeiss LSM 700) in the tile scan mode was used to capture a mosaic of images.
Fluorescence was quantified using the Fiji software. Average fluorescence estimates were calculated from 1,769 non-infected cells and 1,532 MTB-infected cells.
RNA-Seq data processing and identification of differently expressed genes upon MTB
infection. Adaptor sequences and low quality score bases were first trimmed using Trim Galore.
The resulting reads were aligned to the human genome reference sequence (GRCh37/hg19) using the TopHat2 software package 54 with a TopHat transcript index from RefSeq. The number of read fragments overlapping with annotated exons of genes was tabulated using HTSeq 55 using the following parameters: -q -m intersection-nonempty -s no. Using normalized gene counts for 6 infected and 6 non-infected samples, we identified genes whose expression levels were significantly altered following MTB infection of DCs using the R package DESeq2 56 and h = 200. Bsmooth implements a smoothing method that uses a local likelihood approach to estimate the smoothed probability of methylation at each site, taking into account the spatial correlation between nearby sites and placing greater weight on sites with higher coverage. To minimize noise in methylation estimates due to low-coverage data, we restricted the differential methylation analysis to CpG sites with coverage of ≥4 sequence reads in at least half of the DC samples in each condition, which still allowed us to interrogate changes in methylation levels at ~20 million CpG sites. Moreover, to eliminate effects caused by polymorphisms, C nucleotides that overlapped with known SNPs (dbSNP132; http://www.ncbi.nlm.nih.gov/SNP/) were removed. We identified MTB-induced differentially methylated regions (MTB-DMRs) as regions containing at least 3 consecutive CpG sites that were significantly differentially methylated using a paired t-test (|t-statistic| > 4.032 at P = 0.01) and exhibited at least a 10% difference in mean methylation levels between treated and untreated samples.
Assigning MTB-DMRs to genes.
To assign each MTB-DMR to a gene, we use the following rationale: if an MTB-DMR was located within a gene body the MTB-DMR was assigned to that gene; otherwise, we assigned each MTB-DMR to the closest TSS from the center position of the MTB-DMR. If the closest TSS was further away than 250 kb the gene assigned to that MTB-DMR was not included in any of the downstream analysis. 5hmC analysis. Metagene profiles of 5hmC were plotted as described above for the 5mC data.
To plot 5hmC profiles around MTB-DMRs, the weighted mean methylation was calculated for each contiguous 100-bp bin from 3 kb upstream to 3 kb downstream of the central position of the MTB-DMR. Only CpG sites with sequencing coverage ≥4 were included in the analyses.
Chromatin state annotation and dynamics. We used ChromHMM 23 with default parameters to segment the genome into different chromatin states based on six histone modifications and ChIP input. A model was learned separately for both conditions (i.e., infected and non-infected samples), producing segmentations based on the most likely state assignment of the model. We selected a 12-state model in order to allow sufficient resolution to resolve biologically meaningful chromatin patterns. We further combined segments that had comparable histone patterns, resulting in 7 biologically meaningful chromatin states (Supplementary Fig. 3) . To evaluate the enrichment of each chromatin state at MTB-DMRs, we first assigned each MTB-DMR to a particular chromatin state based on the chromHMM segment overlapping with its midpoint. We then calculated the frequency of MTB-DMRs that were assigned to a particular chromatin state, and normalized this value against the expected frequency based on the amount of genome covered by that state. We note that we have also performed similar analyses using a unified model that learns and defines chromatin states in both infected and non-infected DCs at the same time (in contrast to doing it separately in each condition) and all our results and conclusions remain virtually the same (Supplementary Fig. 12) .
To test the hypothesis that regions that changed DNA methylation are also more likely to change chromatin state (compared to other regions of the genome), we randomly sampled an equal number of regions matched for the same chromatin states observed within hyper-and hypomethylated MTB-DMRs in non-infected DCs. We then counted the proportion of these random regions that changed chromatin state after infection. The expected distribution of chromHMM state transitions was generated using 1000 simulations and was compared to the proportion of chromatin changes observed among hyper-and hypomethylated regions. A similar resampling strategy was used to test for an enrichment of hypomethylated regions marked as heterochromatin/repressed before infection and that gained de novo enhancer marks upon MTB infection.
Enhancer classification of hypomethylated regions based on chromatin state. In order to define different categories of enhancers, we centered our analysis on H3K4me1 signals. If H3K4me1 was present in the basal state, such region was defined as a predefined enhancer.
Therefore, predefined enhancers were simply defined as regions that overlapped with a chromHMM segment of either state 3, 4, or 5 (active or inactive enhancers) prior to MTB infection. If H3K4me1 was not found to be enriched against input in the basal (untreated) state but H3K4me1 and/or H3K27ac were induced by MTB infection, the region was defined as a de novo enhancer. Therefore, de novo enhancers were defined as regions that overlapped with a chromHMM segment of state 7 (heterochromatin/repressed) that transitioned to either state 3, 4, or 5 (active or inactive enhancers) after MTB infection. Sequencing read data visualization. Sequencing experiments were visualized by preparing custom tracks for the WashU Epigenome browser (http://epigenomegateway.wustl.edu/). ATAC-Seq data processing and footprinting analysis. ATAC-Seq 29 reads were mapped to the human reference genome (GRCh37/hg19) using BWA-MEM 61 , at default parameters. Only reads that had a unique alignment and mapping quality of ≥10 were retained. Similarly, ngs.plot was used to plot ATAC-Seq profiles around MTB-DMRs. To detect TF binding footprints in the ATAC-Seq data we used the program Centipede 31 in two steps. In the first step, we determined which transcription factors were active (have motif instances with footprints) before and after infection using a reduced set of motif instances (5K-15K) for each TF as defined in Moyerbrailean et al. 62 . In the second step, we scanned the entire genome for motif instances matching the original PWM, and we ran Centipede in parallel for the two conditions in order to make the posterior probabilities comparable. For both steps, to run Centipede the aligned pairedend reads are separated into four bins depending on the fragment length ( [40, 99] , [100, 139], [140, 179] and [180, 250] in bp). As Tn5 transposase contacts and duplicates 9 bp of DNA 29 we take as the cleavage site the middle nucleotide. To do so, we shifted 4 bp from the 5'-end positions towards the center of the fragment. Then for each motif we built a matrix that counted Tn5 cleavage events, where each row represented a motif instance (i.e., a candidate binding site), and each column represented a spatial location with respect to the TF binding site in bp (i.e., relative cleavage site). This matrix was constructed separately for each fragment length bin and each strand orientation (with respect to the motif match, or reference strand if motif was palindromic). We used a window size of 300 bp on either side of the motif match. We then concatenated all 8 matrices and fed them as input data to Centipede, together with the PWM score.
ChIP
For determining which TFs are active on the first step, we calculate a Z-score corresponding to the PWM effect in the prior probability in Centipede's logistic model and we determine as active those that have a Bonferroni-corrected P < 0.05. The Z-score corresponds to the ! parameter in:
where ! l represent the prior probability of binding in Centipede's model in motif location l . On the second step, we first train Centipede assuming that the footprint is bound in the two conditions. Then, we fix the model parameters and we generate a likelihood ratio and posterior probability ! lt for each condition t separately and for each site l . To detect if the footprint is more active in one of the two conditions, we fit a logistic model that includes an intercept for each condition (! and ! ), the PWM effect ! , and PWM times the treatment effect ! : where I t is an indicator variable that takes the value 1 if t = "treatment" and 0 if t = "control''.
We calculate a Z-score for the interaction effect ! that measures if there is condition specific binding.
Gene Set Enrichment Analysis. We used Genetrail 63 to test for enrichment of functional annotations among genes nearby MTB-DMRs (<250 kb), using the set of all Ensembl genes as a background. Analysis was done with default parameters and results corrected for multiple testing by the method of Benjamini and Hochberg to control the False Discovery Rate (FDR).
